Cargando…
Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET Agents
[Image: see text] Mesothelin (MSLN) is a tumor-associated antigen found in a variety of cancers and is a target for imaging and therapeutic applications in MSLN-expressing tumors. We have developed high affinity anti-MSLN human VH domain antibodies, providing alternative targeting vectors to convent...
Autores principales: | Sun, Zehua, Jaswal, Ambika P., Chu, Xiaojie, Rajkumar, Harikrishnan, Cortez, Angel G., Edinger, Robert, Rose, Max, Josefsson, Anders, Bhise, Abhinav, Huang, Ziyu, Ishima, Rieko, Mellors, John W, Dimitrov, Dimiter S., Li, Wei, Nedrow, Jessie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666227/ https://www.ncbi.nlm.nih.gov/pubmed/38027361 http://dx.doi.org/10.1021/acsomega.3c04492 |
Ejemplares similares
-
Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate
por: Sun, Zehua, et al.
Publicado: (2023) -
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [(225)Ac]Ac-DOTA-TDA-Lipiodol(®) against hepatic tumors
por: Josefsson, Anders, et al.
Publicado: (2023) -
Construction of a Large Size Human Immunoglobulin Heavy Chain Variable (VH) Domain Library, Isolation and Characterization of Novel Human Antibody VH Domains Targeting PD-L1 and CD22
por: Sun, Zehua, et al.
Publicado: (2022) -
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
por: Liu, Xianglei, et al.
Publicado: (2020) -
Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma
por: Du, Yong, et al.
Publicado: (2022)